Factors associated with colorectal cancer occurrence after colonoscopy that did not diagnose colorectal cancer

被引:27
作者
Cheung, Danny [1 ]
Evison, Felicity [2 ]
Patel, Prashant [3 ]
Trudgill, Nigel [1 ]
机构
[1] Sandwell Gen Hosp, Dept Gastroenterol, West Bromwich, England
[2] Queen Elizabeth Hosp, Hlth Informat Dept, Birmingham, W Midlands, England
[3] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England
关键词
SURVIVAL; INTERVAL; UK; PREDICTORS; IMPACT; RATES; TIME;
D O I
10.1016/j.gie.2016.01.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Up to 6% of colorectal cancers (CRCs) are diagnosed within 5 years of a colonoscopy that did not diagnose CRC (post-colonoscopy colorectal cancer, PCCRC). PCCRC and associated risk factors were examined within a national hospital episode database. Methods: A retrospective case-control study of all colonoscopies performed on adults recorded in Hospital Episode Statistics (HES) between 2003 and 2009 in England. PCCRC cases underwent colonoscopy 6 to 60 months before diagnosis; controls had not undergone colonoscopy 6 to 60 months before diagnosis. Multivariate logistic regression analysis examined associations with PCCRC. Results: A total of 1,439,684 colonoscopies were analyzed, including 67,202 cases of CRC and 8147 cases of PCCRC (12.1%). Multivariate analysis revealed that female sex (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.08-1.19; P <.001), older age (70-74 years) (OR, 1.09; 95% CI, 1.00-1.18; P = . 039), increased comorbidity (Charlson index 5+) (OR, 1.16; 95% CI, 1.05-1.28; P <.003), and CRC of the right side of the colon (OR, 1.17; 95% CI, 1.11-1.23; P <.0001) were associated with PCCRC. Emergency colonoscopy (OR, 0.54; 95% CI, 0.59-0.69; P <.0001) was negatively associated with PCCRC. More individuals with PCCRC developed metastases within 12 months and fewer underwent surgery (OR, 0.33; 95% CI, 0.32-0.35; P <.0001) or chemotherapy (OR, 0.66; 95% CI, 0.62-0.69), P <.0001). PCCRC rates varied 2-fold between providers and PCCRC was associated with medium-volume providers compared with high-volume providers (OR, 1.13; 95% CI, 1.01-1.27; PZ. 035). The PCCRC rate fell from 13.8% in 2003 to 11.9% in 2009. Conclusions: PCCRC occurred in 12.1% of patients with CRC between 2003 and 2009. PCCRC was associated with female sex, older age, increased comorbidity, CRC of the right side of the colon, elective procedures, and colonoscopy volume. PCCRC was associated with worse outcomes.
引用
收藏
页码:287 / +
页数:10
相关论文
共 28 条
[1]  
[Anonymous], HOSP EP STAT
[2]   A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation [J].
Aoun, E ;
Abdul-Baki, H ;
Azar, C ;
Mourad, F ;
Barada, K ;
Berro, Z ;
Tarchichi, M ;
Sharara, AI .
GASTROINTESTINAL ENDOSCOPY, 2005, 62 (02) :213-218
[3]   CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle [J].
Arain, Mustafa A. ;
Sawhney, Mandeep ;
Sheikh, Shehla ;
Anway, Ruth ;
Thyagarajan, Bharat ;
Bond, John H. ;
Shaukat, Aasma .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05) :1189-1195
[4]   Analysis of Administrative Data Finds Endoscopist Quality Measures Associated With Postcolonoscopy Colorectal Cancer [J].
Baxter, Nancy N. ;
Sutradhar, Rinku ;
Forbes, Shawn S. ;
Paszat, Lawrence F. ;
Saskin, Refik ;
Rabeneck, Linda .
GASTROENTEROLOGY, 2011, 140 (01) :65-72
[5]   A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? [J].
Bowles, CJA ;
Leicester, R ;
Romaya, C ;
Swarbrick, E ;
Williams, CB ;
Epstein, O .
GUT, 2004, 53 (02) :277-283
[6]   Rates of new or missed colorectal cancers after colonoscopy and their risk factors: A population-based analysis [J].
Bressler, Brian ;
Paszat, Lawrence F. ;
Chen, Zhongliang ;
Rothwell, Deanna M. ;
Vinden, Chris ;
Rabeneck, Linda .
GASTROENTEROLOGY, 2007, 132 (01) :96-102
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data [J].
Coleman, M. P. ;
Forman, D. ;
Bryant, H. ;
Butler, J. ;
Rachet, B. ;
Maringe, C. ;
Nur, U. ;
Tracey, E. ;
Coory, M. ;
Hatcher, J. ;
McGahan, C. E. ;
Turner, D. ;
Marrett, L. ;
Gjerstorff, M. L. ;
Johannesen, T. B. ;
Adolfsson, J. ;
Lambe, M. ;
Lawrence, G. ;
Meechan, D. ;
Morris, E. J. ;
Middleton, R. ;
Steward, J. ;
Richards, M. A. .
LANCET, 2011, 377 (9760) :127-138
[9]   Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries [J].
Cooper, Gregory S. ;
Xu, Fang ;
Sloan, Jill S. Barnholtz ;
Schluchter, Mark D. ;
Koroukian, Siran M. .
CANCER, 2012, 118 (12) :3044-3052
[10]   Characteristics and Survival of Interval and Sporadic Colorectal Cancer Patients: A Nationwide Population-Based Cohort Study [J].
Erichsen, Rune ;
Baron, John A. ;
Stoffel, Elena M. ;
Laurberg, Soren ;
Sandler, Robert S. ;
Sorensen, Henrik Toft .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (08) :1332-1340